BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5–11 Years of Age: A Test Negative Design

In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47−69] <3 months post-dose-two and 28% [8−43] aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Tartof, Sara Y, Frankland, Timothy B, Puzniak, Laura, Slezak, Jeff M, Hong, Vennis, Takhar, Harpreet, Ogun, Oluwaseye A, Simmons, Sarah, Xie, Fagen, Zamparo, Joann, Ackerson, Bradley K, Jodar, Luis, McLaughlin, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112675/
https://www.ncbi.nlm.nih.gov/pubmed/36715070
http://dx.doi.org/10.1093/jpids/piad005
Descripción
Sumario:In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47−69] <3 months post-dose-two and 28% [8−43] after ≥3 months. A booster improved protection to 77% [53−88].

Ejemplares similares